YESTAR HEALTH (02393) announced its performance for 2025, with a net loss attributable to owners of the company of 75.03 million yuan, a change from profit to loss compared to the previous year.

date
00:09 28/03/2026
avatar
GMT Eight
Superstar Medical Holdings (02393) announced its performance for 2025, with a continuous operating income of approximately 1.49 billion yuan, a year-on-year decrease of 38.17%; the company's owners' share of losses was 75.03 million yuan, a year-on-year switch from profit to loss; loss per share was 3.22 cents.
Yestar Health (02393) announced its performance for 2025, with continuing operating revenue of approximately 1.49 billion yuan, a decrease of 38.17% year-on-year. The company's net loss attributable to owners amounted to 75.03 million yuan, a change from profit to loss year-on-year; resulting in a loss of 3.22 cents per share.